GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (OTCPK:SARTF) » Definitions » Median PS Value

Sartorius AG (Sartorius AG) Median PS Value : $261.69 (As of Apr. 26, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sartorius AG Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Sartorius AG's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $52.677. Sartorius AG's 10-Year median PS Ratio is 4.9678. Therefore, the Median PS Value for today is $261.69.

As of today (2024-04-26), Sartorius AG's share price is $247.03. Sartorius AG's Median PS Value is $261.69. Therefore, Sartorius AG's Price to Median PS Value for today is 0.94.

The historical rank and industry rank for Sartorius AG's Median PS Value or its related term are showing as below:

SARTF' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.87   Med: 2.65   Max: 3.65
Current: 0.94

During the past 13 years, the highest Price to Median PS Value of Sartorius AG was 3.65. The lowest was 0.87. And the median was 2.65.

SARTF's Price-to-Median-PS-Value is ranked worse than
59.29% of 312 companies
in the Medical Devices & Instruments industry
Industry Median: 0.785 vs SARTF: 0.94

Sartorius AG Median PS Value Historical Data

The historical data trend for Sartorius AG's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Median PS Value Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.10 122.80 204.98 277.70 269.37

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 293.40 288.28 278.09 269.37 271.29

Competitive Comparison of Sartorius AG's Median PS Value

For the Medical Instruments & Supplies subindustry, Sartorius AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius AG's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius AG's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Sartorius AG's Price-to-Median-PS-Value falls into.



Sartorius AG Median PS Value Calculation

Sartorius AG's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=52.677*4.9678
=261.69

10-Year Median PS Ratio is 4.9678.
Sartorius AG's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $52.677.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sartorius AG  (OTCPK:SARTF) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Sartorius AG's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=247.03/261.69
=0.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sartorius AG Median PS Value Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius AG (Sartorius AG) Business Description

Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.

Sartorius AG (Sartorius AG) Headlines

From GuruFocus

Sartorius closes acquisition of BIA Separations

By PRNewswire PRNewswire 11-02-2020

Strong profitable growth at Sartorius

By PRNewswire PRNewswire 10-20-2020

Sartorius presents annual report for 2021

By PRNewswire PRNewswire 02-17-2022

Sartorius with continued growth in a challenging environment

By PRNewswire PRNewswire 10-19-2022

Sartorius to Open New Application and Service Hub in Shanghai

By PRNewswire PRNewswire 09-16-2021

Sartorius acquires cell culture specialist Xell AG

By PRNewswire PRNewswire 07-29-2021

Sartorius To Join The DAX Blue Chip Index

By PRNewswire PRNewswire 09-04-2021